RxDoctor Payments Data

William Sudduth, PA

Physician Assistant · Lexington, KYNPI 1225043730

Payments from drug & device makers

$2,050in general payments, 2019–2025

Across 108 payments — averaging $18.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$542
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$353
  • Abbott$167
  • Amgen$116
  • Impulse Dynamics (USA) Inc.$109
  • Philips North America LLC$108
  • plus $656 from 18 others

What the payments were for

  • Food & beverage$2,050100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,050 in reported general payments places this provider in the 75th percentile of 1,448 physician assistant providers in Kentucky.

See all physician assistant providers in Kentucky

Medicare billing

Part B allowed, 2024
$94,255
Medicare patients
674
Services billed
1,514

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban579$526,046
XareltoRivaroxaban90$86,369
EntrestoSacubitril/Valsartan89$77,704
JardianceEmpagliflozin37$29,103
MultaqDronedarone Hcl24$18,754
Dofetilide95$10,173
Flecainide Acetate236$7,948
Propafenone Hcl ErPropafenone Hcl25$5,571
Diltiazem 24hr Er (Cd)Diltiazem Hcl115$3,004
Metoprolol Succinate268$2,578
Propafenone Hcl12$1,454
SotalolSotalol Hcl85$1,334
Metoprolol Tartrate282$1,057
Amiodarone Hcl87$993
Valsartan56$909

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$41$526,046579 claims
Johnson & JohnsonXarelto$13$86,36990 claims
NovartisEntresto$68$77,70489 claims
Boehringer IngelheimJardiance$28$29,10337 claims
Sanofi-aventis U.S. LLCMultaq$14$18,75424 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,448 physician assistant providers in Kentucky.

Other physician assistant in Lexington

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →